Related Experiment Video

Updated: Jun 19, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease

Ryan S Friese1, Fangwen Rao, Srikrishna Khandrika

  • 1Department of Medicine, University of California, San Diego, CA, USA.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|November 6, 2009
PubMed

Insights

Matrix metalloproteinase (MMP) enzymes are linked to hypertension and kidney damage. MMP-9 levels increase with hypertension, while MMP-2 and MMP-10 indicate severe kidney damage in hypertensive patients.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Nephrology

Background:

  • Inflammation plays a role in hypertension and target organ damage.
  • Matrix metalloproteinases (MMPs) are inflammatory mediators implicated in hypertension.
  • Understanding MMP involvement is crucial for managing hypertensive complications.

Purpose of the Study:

  • To investigate matrix metalloproteinases (MMPs) as inflammatory mediators in hypertension.
  • To analyze MMP levels in uncomplicated hypertension and hypertensive end-stage renal disease (ESRD).
  • To correlate MMP levels with systolic blood pressure (SBP) and renal damage.

Main Methods:

  • Assayed plasma levels of five MMPs: MMP-1 (collagenase), MMP-2 and MMP-9 (gelatinases), and MMP-3 and MMP-10 (stromelysins).
  • Studied three subject groups: normotensive controls, uncomplicated hypertension, and hypertensive ESRD.
  • Correlated MMP levels with SBP and disease severity.

Main Results:

  • MMP-9 was elevated in hypertensive subjects compared to normotensive controls.
  • SBP positively correlated with MMP-9 levels across all groups.
  • MMP-2 and MMP-10 were elevated in hypertensive ESRD patients compared to other groups.
  • Observed correlations between MMPs suggest coordinate regulation.

Conclusions:

  • Hypertension is associated with distinct patterns of MMP overexpression.
  • MMP-9 elevation may indicate early-stage hypertension.
  • Elevated MMP-2 and MMP-10 are linked to significant target organ damage, specifically renal damage in ESRD.
  • MMPs represent potential biomarkers for hypertension severity and progression.

More Related Videos

A Murine Model of Hemodialysis Access-Related Hand Dysfunction08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...